Combat against antibiotic resistance is a challenge in Bangladesh

Miah Roney, AKM Moyeenul Huq, Mohd Fadhlizil Fasihi Mohd Aluwi

Intelligent Pharmacy ›› 2024, Vol. 2 ›› Issue (3) : 305-307.

PDF(215 KB)
PDF(215 KB)
Intelligent Pharmacy ›› 2024, Vol. 2 ›› Issue (3) : 305-307. DOI: 10.1016/j.ipha.2024.02.002

Combat against antibiotic resistance is a challenge in Bangladesh

Author information +
History +

Abstract

To the Editor, Antibiotics are a class of drug used to treat or prevent infections caused by bacteria; they function by either eradicating the organism or stopping its growth. Penicillin, cephalosporins, macrolides, fluoroquinolones, and urinary anti-infectives are examples of common antibiotics. To effectively treat the illness, it’s critical to take antibiotics as directed by a physician and to finish the entire course of treatment. Antibiotic resistance is a serious issue in Bangladesh as a result of subpar healthcare practices, antibiotic abuse, and overuse. Antibiotic resistance is the result of bacteria changing and becoming resistant to an antibiotic’s effects. Moreover, one of Bangladesh’s biggest challenges is the fight against antibiotic resistance. Therefore, the purpose of this letter is to raise awareness of the antibiotic resistance in Bangladesh.

Keywords

Antibiotic resistance / Median resistance / Directorate General of Drug Administration / Bangladesh

Cite this article

Download citation ▾
Miah Roney, AKM Moyeenul Huq, Mohd Fadhlizil Fasihi Mohd Aluwi. Combat against antibiotic resistance is a challenge in Bangladesh. Intelligent Pharmacy, 2024, 2(3): 305‒307 https://doi.org/10.1016/j.ipha.2024.02.002

References

[1]
BiswasM, RoyMN, ManikMIN, et al. Self medicated antibiotics in Bangladesh: a cross-sectional health survey conducted in the Rajshahi City. BMC Publ Health. 2014;14:1–7.
CrossRef Google scholar
[2]
BonnaAS, PavelSR, FerdousJ, Khan SA, AliM. Antibiotic resistance: an increasingly threatening but neglected public health challenge in Bangladesh. International Journal of Surgery Open. 2022;49:100581.
CrossRef Google scholar
[3]
OrubuESF, SamadMA, RahmanMT, Zaman MH, WirtzVJ. Mapping the antimicrobial supply chain in Bangladesh: a scoping-review-based ecological assessment approach. Glob Health Sci Pract. 2021;9(3):532–547.
CrossRef Google scholar
[4]
RoushamEK, IslamMA, NaharP, et al. Pathways of antibiotic use in Bangladesh: qualitative protocol for the PAUSE study. BMJ Open. 2019;9(1):e028215.
CrossRef Google scholar
[5]
AhmedI, RabbiMB, SultanaS. Antibiotic resistance in Bangladesh: a systematic review. Int J Infect Dis. 2019;80:54–61.
CrossRef Google scholar
[6]
HoqueR, AhmedSM, NaherN, et al. Tackling antimicrobial resistance in Bangladesh: a scoping review of policy and practice in human, animal and environment sectors. PLoS One. 2020;15(1):e0227947. https://commonwealthpharmacy.org/fighting-antimicrobial-resistance-in-bangladesh/. https://dgda.portal.gov.bd/sites/default/files/files/dgda.portal.gov.bd/files/a884dd82_db40_4cC9_bC72_e929b8553fd3/2023-12-29-19-23-951945f2793082187e830fed6fe11aed.pdf. https://www.who.int/bangladesh/news/detail/07-03-2023-establishing-red-label-of-antibiotics-for-curbing-ant imicrobial-resistance-in-bangladesh.
[7]
AhmedSM, NaherN, TuneSNBK, Islam BZ. The Implementation of National Action Plan (NAP) on Antimicrobial Resistance (AMR) in Bangladesh: challenges and lessons learned from a cross-sectional qualitative study. Antibiotics. 2022;11(5):690.
CrossRef Google scholar

RIGHTS & PERMISSIONS

2024 2024 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.
AI Summary AI Mindmap
PDF(215 KB)

Accesses

Citations

Detail

Sections
Recommended

/